{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-022580","form_type":"8-K","ticker":"STXS","cik":"0001289340","company_name":"Stereotaxis, Inc.","filed_at":"2025-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.595359+00:00","generated_at":"2026-05-17T17:10:01.247075+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Stereotaxis Q2 revenue surges 95% to $8.8M; net loss narrows to $3.8M","bullets":["Revenue $8.8M (+95% YoY, +18% seq); system revenue $3.0M (vs $0.2M), recurring $5.8M (+35% YoY).","Net loss $3.8M vs $5.8M; adjusted net loss $1.3M vs $3.3M; gross margin 52%.","Cash $7.0M at June 30; July $12.5M financing closed; pro forma cash $18.8M, no debt.","Guidance: double-digit FY2025 revenue growth; Q4 recurring ~$7M; system $2-3M/quarter.","FDA clearance for MAGiC Sweep catheter; initial sales in Q2; further approvals expected near-term."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-022580","json":"https://secwatch.observer/filing/0001641172-25-022580.json","markdown":"https://secwatch.observer/filing/0001641172-25-022580.md","text":"https://secwatch.observer/filing/0001641172-25-022580.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1289340/000164117225022580/0001641172-25-022580-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1289340/000164117225022580/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T17:10:01.247075+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}